Gilead Sciences to purchase the biologics process research and clinical manufacturing facility from Roche's Genentech Inc. unit

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Gilead Sciences Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$29,130.1m on 08/05/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced